Drug transporters in drug disposition - highlights from the year 2023.

Drug Metab Rev

Drug Metabolism and Pharmacokinetics Research Laboratories, Takeda irinote Pharmaceutical Company Limited, Fujisawa, Japan.

Published: November 2024

Drug transporter field is rapidly evolving with significant progress in and tools and, computational models to assess transporter-mediated drug disposition and drug-drug interactions (DDIs) in humans. On behalf of all coauthors, I am pleased to share the fourth annual review highlighting articles published and deemed influential in the field of drug transporters in the year 2023. Each coauthor independently selected peer-reviewed articles published or available online in the year 2023 and summarized them as shown previously (Chothe et al. 2021; Chothe et al. 2022, 2023) with unbiased perspectives. Based on selected articles, this review was categorized into four sections: (1) transporter structure and evaluation, (2) novel / models, (3) endogenous biomarkers, and (4) PBPK modeling for evaluating transporter DDIs (Table 1). As the scope of this review is not to comprehensively review each article, readers are encouraged to consult original paper for specific details. Finally, I appreciate all the authors for their time and continued support in writing this review.

Download full-text PDF

Source
http://dx.doi.org/10.1080/03602532.2024.2399523DOI Listing

Publication Analysis

Top Keywords

year 2023
12
drug transporters
8
drug disposition
8
articles published
8
chothe et al
8
drug
5
review
5
transporters drug
4
disposition highlights
4
highlights year
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!